United Kingdom · Investor

Medicxi

Last cheque observed Aug 2026; 10 cheques on record.

VC firmDeploying nowNew fund $290M, Sept 2025

SeedSeries ASeries BBiopharmaBiotechnologyLife Science

Deploying now
100%of best year2cheques in 12 months, 10 on record
Since the last cheque96days00hrs00min00sec
Median round$57MRounds led1 of 10Sole investor3 roundsMostly inUnited Kingdom, 50%
Pitch Medicxi

Medicxi highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 63% of its rounds

  3. 03

    Sole investor in 3 rounds, median $12M

What they do

Listed name: MedicxiFrom their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
BiopharmaBiotechnologyLife Science
Based in
United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first10 appearances

  1. 2026

    2 rounds

  2. Aug
    Vaderis TherapeuticsSeries B · CH · Firms' own news pages$152MWith 8 others
  3. Jul
    FORE BiotherapeuticsSeries D · US · Ventureburn$67MLed
  4. 2024

    2 rounds

  5. Dec
    Ottimo PharmaSeries A · GB · Firms' own news pages$140MWith 9 others
  6. Sept
    VicebioSeries B · GB · Firms' own news pages$100MWith 7 others
  7. 2021

    1 round

  8. Sept
    Xenikos B.V.Debt · NL · Firms' own news pages$47MWith 4 others
  9. 2019

    3 rounds

  10. Sept
    Divide and ConquerSeries A · GB · Labiotech$12MSole investor
  11. May
    Phathom PharmaceuticalsUS · FinSMEs$140MWith 8 others
  12. Apr
    Aura BiosciencesSeries D · US · FinSMEs$40MSole investor
  13. 2017

    1 round

  14. Feb
    ApcintexSeries A · GB · FinSMEs$18MWith 1 other
  15. 2015

    1 round

  16. Oct
    Kymo TherapeuticsGB · FinSMEs$12MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration15 named

AWAndrew WignallDirectoriForm ADV
CHChristopher H. PattonDIRECTOR OF THE MANAGING GENERAL PARTNERiFiling they signed
DGDavid GraingerExecutive OfficeriFiling they signed
FDFrancesco De RubertisExecutive OfficeriFiling they signed
FXFrancois Xavier Alain Henri ChesnayDIRECTOR OF THE MANAGING GENERAL PARTNERiFiling they signed
GJGailina Jia-Hsin LiewDirectoriForm ADV
GJGiles Johnstone-ScottDirectoriForm ADV
GHGiovanni H. PericoliniDIRECTOR OF THE MANAGING GENERAL PARTNERiFiling they signed
GMGiovanni MariggiShareholderiForm ADV
GZGiuseppe ZoccoExecutive OfficeriFiling they signed
KJKevin JohnsonExecutive OfficeriFiling they signed
LBLouisa BlanchetDIRECTOR OF THE MANAGING GENERAL PARTNERiFiling they signed
MOMichele OllierExecutive OfficeriFiling they signed
NCNigel CrockerDirectoriForm ADV
RLRichard LeeDirectoriForm ADV

We also hold 17 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$2.4Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Medicxi Ventures Management (jersey) Limited
SEC number
CRD 283504

Who they invest alongside

The investors most often in the same rounds as Medicxi. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Medicxi put money into.

Quick answers about Medicxi

What does Medicxi invest in?

Medicxi invests most often at Series A and Series B (63% of the rounds on record), in sectors such as Biopharma, Biotechnology and Life Science.

How active is Medicxi?

10 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Aug 2026.

What has Medicxi invested in recently?

Its most recent investments on record: Vaderis Therapeutics (Series B, Aug 2026), FORE Biotherapeutics (Series D, Jul 2026) and Ottimo Pharma (Series A, Dec 2024).

How big are Medicxi's cheques?

The median round it joins is $57M.

Does Medicxi lead rounds?

Sometimes: it led 1 of its 10 investments on record (10%).

Where does Medicxi invest?

Most of the companies it backs are in the United Kingdom (50%), the United States (30%) and Switzerland (10%).

Is Medicxi investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does Medicxi invest alongside?

Most often Janus Henderson Investors (2 rounds together), OrbiMed (2 rounds together) and TCG (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it